Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,256,226 papers from all fields of science
Search
Sign In
Create Free Account
U 37883A
Known as:
U 37883
, U-37883
, U-37883A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Adamantane
Diuretics
Morpholines
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
N. Teramoto
Cardiovascular Drug Reviews
2006
Corpus ID: 35449553
U-37883A (PNU-37883A, guanidine; 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexyl hydrochloride) was originally developed as…
Expand
2002
2002
Role Of Nitric Oxide In Mediating Vasodilator Responses To Opioid Peptides In The Rat
H. Champion
,
T. Bivalacqua
,
J. Zadina
,
A. Kastin
,
A. Hyman
,
P. Kadowitz
Clinical and Experimental Pharmacology and…
2002
Corpus ID: 10201927
1. Endomorphins 1 and 2, endogenous ligands for the μ‐opioid receptor, and nociceptin (orphanin FQ; OFQ), an endogenous ligand…
Expand
1999
1999
Responses to propofol in the pulmonary vascular bed of the rat
A. Kaye
,
M. Anwar
,
+4 authors
B. Nossaman
Acta Anaesthesiologica Scandinavica
1999
Corpus ID: 10515636
Background: Although a great deal is known about responses to propofol, controversy remains about its mechanism of action. The…
Expand
1999
1999
Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
G. Wellman
,
R. Barrett-Jolley
,
H. Köppel
,
D. Everitt
,
J. Quayle
British Journal of Pharmacology
1999
Corpus ID: 27189343
1 The aim of this study was to investigate the selectivity of the ATP-sensitive potassium (K(ATP)) channel inhibitor U-37883A (4…
Expand
1998
1998
Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat
H. Champion
,
T. Bivalacqua
,
D. E. Friedman
,
J. Zadina
,
A. Kastin
,
P. Kadowitz
Peptides
1998
Corpus ID: 34687399
1996
1996
Effects of U-37883A, a vascular selective KATP+ channel antagonist, in the pulmonary and hindlimb circulation.
B. Dewitt
,
D. Cheng
,
T. McMahon
,
J. Marrone
,
H. Champion
,
P. J. Kandowitz
American Journal of Physiology
1996
Corpus ID: 24651730
The effects of the vascular selective nonsulfonylurea guanidine ATP-sensitive K+ (KATP+) channel-blocking agent U-37883A on…
Expand
1996
1996
Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
S. J. Humphrey
,
M. P. Smith
,
+4 authors
K. Meisheri
Methods and Findings in Experimental and Clinical…
1996
Corpus ID: 7001040
The cardiovascular effects of the K-ATP channel blocker U-37883A and 5 related morpholinoguanidines were determined in 6…
Expand
1996
1996
Differential sensitivity of venular and arteriolar alpha-adrenergic receptor constriction to inhibition by hypoxia. Role of receptor subtype and coupling heterogeneity.
C. J. Leech
,
J. Faber
Circulation Research
1996
Corpus ID: 7021066
Reflex adrenergic constriction of the venous circulation is considerably less sensitive than the arterial circulation to local…
Expand
Highly Cited
1995
Highly Cited
1995
Pulmonary vasodilation to adrenomedullin: a novel peptide in humans.
John Heaton
,
B. Lin
,
Jaw-Kang Chang
,
Steven M. Steinberg
,
A. L. Hyman
,
H. Lippton
American Journal of Physiology
1995
Corpus ID: 29801573
The present study investigates the effects of human adrenomedullin (ADM) on the pulmonary vascular bed of isolated, blood…
Expand
1995
1995
Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
A. Szewczyk
,
G. Wójcik
,
A. Jabłonowska
,
Nałecz
Polish Journal of Pharmacology
1995
Corpus ID: 43636413
The activity of potassium uniport in rat liver mitochondria was measured using light scattering technique (mitochondrial swelling…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE